Dr. Nathan P. Freeman, MD

Dr. Freeman practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Freeman's NPI, 1932272630, was assigned on November 17, 2006. Dr. Freeman graduated from McGill University Faculty of Medicine in 2001. Dr. Freeman's California license number on file is A104678.

Dr. Freeman's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Freeman's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Freeman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freeman practices. Vendor and product names are available with a free account.

Family medicine is Dr. Freeman's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Freeman is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Freeman's licenses on file in 2 states: California and Texas.

Dmand AI lists adjustment disease, ankle or foot injury, anxiety, aortic atherosclerois, asthma, atrial fibrillation and flutter, bursitis and chronic diabetes among the conditions Dr. Freeman treats.

CMS data shows 329 Medicare services from Dr. Freeman across 7 procedure codes in 2024, for 125 Medicare patients. Medicare paid $28,275 for them. Every service was in an office.

CMS counts 125 Medicare patients who saw Dr. Freeman in 2024. The largest group is 65 to 74, with 67 patients. 70% of them have high cholesterol, and 58% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Freeman's median patient age at 54, with 33% women.

In 2024, Dr. Freeman wrote 3,347 Medicare Part D claims for 326 patients. 91% of them were for generic drugs. CMS names the drug for 2,724 of them, across 71 drugs with 11 or more claims each, at $150,558 in total drug cost. In 2023, CMS named 2,754 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Freeman for performance year 2024, reported as part of a group. Dr. Freeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Freeman as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1 general payment to Dr. Freeman from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $13.

Dmand AI lists 1 award for Dr. Freeman, most recently Master Clinician in 2012.

Dr. Freeman graduated from McGill University Faculty of Medicine in 2001.

Dr. Freeman is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.